Abrocitinib
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Cibinqo (abrocitinib) is an oral prescription medication manufactured by Pfizer, classified as a Janus Kinase inhibitor. It's used to treat moderate-to-severe atopic dermatitis (eczema) in adults and adolescents. Available in tablet form with strengths of 50mg, 100mg, and 200mg. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Abrocitinib
Access the FDA dataset for Abrocitinib β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025